Gemcitabine specifically is a nucleoside metabolic inhibitor used as an adjunct therapy for treating certain sorts of ovarian cancer, NSCLC, metastatic breast cancer, and as a single agent for pancreatic cancer. The usually varies depending upon branded to non-branded (generic) version drugs.
The drug gemcitabine is available as a powder to be mixed with liquid in order to be injected over 30 minutes intravenously (into a vein) by a healthcare professional. Treatment with gemcitabine should be stopped or delayed in case the patients experience certain adverse reactions.